BURKITT-LIKE LYMPHOMA WITH 11Q ABERRATION

Clinical trials for BURKITT-LIKE LYMPHOMA WITH 11Q ABERRATION explained in plain language.

Never miss a new study

Get alerted when new BURKITT-LIKE LYMPHOMA WITH 11Q ABERRATION trials appear

Sign up with your email to follow new studies for BURKITT-LIKE LYMPHOMA WITH 11Q ABERRATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Targeted drug combo offers hope for Tough-to-Treat leukemia

Disease control Recruiting now

This study is testing a combination of a targeted cancer drug (inotuzumab ozogamicin), low-intensity chemotherapy, and an immunotherapy drug (blinatumomab) for adults with acute lymphoblastic leukemia (ALL). It focuses on older patients (60+) or younger patients who are too frail…

Matched conditions: BURKITT-LIKE LYMPHOMA WITH 11Q ABERRATION

Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

BURKITT-LIKE LYMPHOMA WITH 11Q ABERRATION

Get alerted when new BURKITT-LIKE LYMPHOMA WITH 11Q ABERRATION trials appear

Targeted drug combo offers hope for Tough-to-Treat leukemia